GW Pharmaceuticals Releases a Q4 Revenue Beat but Will the Rapid Growth Continue.

This post was originally published on this site

A 7% revenue beat was cheered by the markets, but with revenue growth slowing can the stock keep the momentum going?

Thanks! You've already liked this
No comments